Market Closed -
Xetra
09:05:46 25/10/2023 pm IST
|
5-day change
|
1st Jan Change
|
63.84
EUR
|
+0.09%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,749
|
9,400
|
10,810
|
10,826
|
9,838
|
8,426
|
-
|
-
|
Enterprise Value (EV)
1 |
10,400
|
9,678
|
11,564
|
11,858
|
12,018
|
10,376
|
10,124
|
9,961
|
P/E ratio
|
14.3
x
|
23.3
x
|
17.5
x
|
20.4
x
|
24
x
|
16.9
x
|
13.8
x
|
12.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.98
x
|
0.93
x
|
0.87
x
|
0.86
x
|
0.8
x
|
0.63
x
|
0.6
x
|
0.57
x
|
EV / Revenue
|
1.04
x
|
0.96
x
|
0.93
x
|
0.94
x
|
0.97
x
|
0.78
x
|
0.72
x
|
0.68
x
|
EV / EBITDA
|
11.3
x
|
12.9
x
|
10.8
x
|
12.4
x
|
12.2
x
|
9.27
x
|
8.31
x
|
7.65
x
|
EV / FCF
|
18
x
|
17.6
x
|
18.3
x
|
23.4
x
|
34
x
|
18
x
|
15.5
x
|
13.6
x
|
FCF Yield
|
5.56%
|
5.68%
|
5.45%
|
4.27%
|
2.94%
|
5.56%
|
6.47%
|
7.35%
|
Price to Book
|
3.18
x
|
2.8
x
|
3.12
x
|
3.05
x
|
2.68
x
|
1.9
x
|
1.65
x
|
1.46
x
|
Nbr of stocks (in thousands)
|
1,46,740
|
1,42,776
|
1,38,674
|
1,35,548
|
1,29,938
|
1,28,051
|
-
|
-
|
Reference price
2 |
66.44
|
65.84
|
77.95
|
79.87
|
75.71
|
65.80
|
65.80
|
65.80
|
Announcement Date
|
20/02/20
|
17/02/21
|
15/02/22
|
16/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
9,986
|
10,119
|
12,401
|
12,647
|
12,339
|
13,346
|
14,019
|
14,704
|
EBITDA
1 |
917.9
|
752.9
|
1,069
|
959
|
984
|
1,119
|
1,218
|
1,303
|
EBIT
1 |
733
|
567.4
|
859.6
|
747
|
615
|
824.1
|
912.6
|
999.2
|
Operating Margin
|
7.34%
|
5.61%
|
6.93%
|
5.91%
|
4.98%
|
6.18%
|
6.51%
|
6.79%
|
Earnings before Tax (EBT)
1 |
680.3
|
499.9
|
830.5
|
721
|
542
|
771.6
|
923.4
|
975.3
|
Net income
1 |
694.7
|
403.8
|
631.2
|
538
|
416
|
520.1
|
642.3
|
723.4
|
Net margin
|
6.96%
|
3.99%
|
5.09%
|
4.25%
|
3.37%
|
3.9%
|
4.58%
|
4.92%
|
EPS
2 |
4.650
|
2.820
|
4.450
|
3.910
|
3.160
|
3.895
|
4.754
|
5.322
|
Free Cash Flow
1 |
577.9
|
550.1
|
630.6
|
506
|
353
|
577
|
655
|
732.5
|
FCF margin
|
5.79%
|
5.44%
|
5.08%
|
4%
|
2.86%
|
4.32%
|
4.67%
|
4.98%
|
FCF Conversion (EBITDA)
|
62.95%
|
73.06%
|
58.98%
|
52.76%
|
35.87%
|
51.55%
|
53.76%
|
56.23%
|
FCF Conversion (Net income)
|
83.18%
|
136.23%
|
99.89%
|
94.05%
|
84.86%
|
110.93%
|
101.98%
|
101.26%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
17/02/21
|
15/02/22
|
16/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
3,331
|
3,179
|
3,030
|
3,067
|
3,371
|
3,060
|
3,100
|
3,162
|
3,017
|
3,172
|
3,271
|
3,377
|
3,530
|
3,343
|
3,410
|
EBITDA
1 |
263.8
|
299
|
273
|
263
|
124
|
257
|
250
|
259
|
172
|
255
|
280.7
|
296.3
|
301.3
|
271
|
304.2
|
EBIT
1 |
205.1
|
244
|
220
|
211
|
72
|
175
|
201
|
200
|
39
|
150
|
211.7
|
224.3
|
234.8
|
196.5
|
229.7
|
Operating Margin
|
6.16%
|
7.68%
|
7.26%
|
6.88%
|
2.14%
|
5.72%
|
6.48%
|
6.33%
|
1.29%
|
4.73%
|
6.47%
|
6.64%
|
6.65%
|
5.88%
|
6.74%
|
Earnings before Tax (EBT)
1 |
193
|
239
|
214
|
205
|
63
|
163
|
186
|
179
|
14
|
127
|
196.6
|
208.5
|
222.4
|
202.2
|
230.3
|
Net income
1 |
147.2
|
181
|
160
|
150
|
47
|
121
|
140
|
137
|
18
|
93
|
139.2
|
149.3
|
159.4
|
145.3
|
163
|
Net margin
|
4.42%
|
5.69%
|
5.28%
|
4.89%
|
1.39%
|
3.95%
|
4.52%
|
4.33%
|
0.6%
|
2.93%
|
4.26%
|
4.42%
|
4.52%
|
4.35%
|
4.78%
|
EPS
2 |
1.050
|
1.300
|
1.160
|
1.090
|
0.3400
|
0.9100
|
1.060
|
1.050
|
0.1300
|
0.7200
|
0.9900
|
1.102
|
1.177
|
1.116
|
1.231
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/02/22
|
03/05/22
|
02/08/22
|
01/11/22
|
16/02/23
|
09/05/23
|
07/08/23
|
13/11/23
|
27/02/24
|
07/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
651
|
278
|
755
|
1,032
|
2,180
|
1,950
|
1,698
|
1,535
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.7088
x
|
0.3689
x
|
0.7058
x
|
1.076
x
|
2.215
x
|
1.742
x
|
1.394
x
|
1.178
x
|
Free Cash Flow
1 |
578
|
550
|
631
|
506
|
353
|
577
|
655
|
733
|
ROE (net income / shareholders' equity)
|
23.3%
|
12.7%
|
18.6%
|
18.2%
|
16.7%
|
15.2%
|
15.1%
|
14.2%
|
ROA (Net income/ Total Assets)
|
8.88%
|
5.41%
|
7.88%
|
8.67%
|
6.18%
|
6.18%
|
6.67%
|
6.77%
|
Assets
1 |
7,826
|
7,462
|
8,008
|
6,205
|
6,731
|
8,411
|
9,635
|
10,693
|
Book Value Per Share
2 |
20.90
|
23.50
|
25.00
|
26.10
|
28.30
|
34.70
|
39.90
|
45.20
|
Cash Flow per Share
2 |
4.380
|
4.180
|
5.010
|
4.370
|
3.800
|
7.100
|
5.630
|
-
|
Capex
1 |
76.2
|
48.8
|
79
|
96
|
147
|
125
|
116
|
121
|
Capex / Sales
|
0.76%
|
0.48%
|
0.64%
|
0.76%
|
1.19%
|
0.94%
|
0.83%
|
0.82%
|
Announcement Date
|
20/02/20
|
17/02/21
|
15/02/22
|
16/02/23
|
27/02/24
|
-
|
-
|
-
|
Last Close Price
65.8
USD Average target price
79.42
USD Spread / Average Target +20.69% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.65% | 137.65Cr | | -13.34% | 127.75Cr | | -5.79% | 120.05Cr | | -26.51% | 77Cr | | -.--% | 62Cr | | +3.68% | 47Cr | | +2.04% | 43Cr | | -31.93% | 30Cr | | -62.49% | 27Cr |
Medical Equipment Wholesale
|